Basel, 9 - 10 October 2024
Schedule
Create your personal agenda –check the favourite icon
Oct 99:00
Conference pass
Keynote presentation: How will AI change the life science industry
Keynotes
Patrick Moeller, CIO, Bayer Pharmaceuticals
Oct 99:20
Conference pass
Innovate to Transform: R&D's Impact on Healthcare Evolution
Keynotes
Pratap Khedkar, CEO, ZS Associates Inc
Oct 910:00
Conference pass
Panel discussion: The benefits of AI within drug discovery
Keynotes
Bulent Kızıltan, Vice President and Global Head of AI & Computational Sciences, Novartis
Julie Huxley-Jones, VP of Research Solutions, GlaxoSmithKline
Oct 911:40
Conference pass
Chair's remarks
Large Language Models
Marion Legler, Head of Decision Science & Advanced Analytics for Medical Affairs, Pharmacovigilance & Regulatory Affairs, Bayer
Oct 911:40
Conference pass
Chair's remarks
Cheminformatics
Werngard Czechtizky, Chair of AZ Global Chemistry Leadership, Astrazeneca
Oct 911:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Oct 911:40
Conference pass
Oct 911:40
Conference pass
Chair's remarks
Analytics Platform
Alexey Rak, Head Of Bio Structure And Biophysics, Sanofi
Oct 911:40
Conference pass
Chair's remarks
Big Data in Oncology
Philipp Pauli, Head of Oncology Europe & Canada, a.i., Takeda
Oct 911:40
Conference pass
Chair's remarks
Data Integration + FAIR
Alexander Sherman, Director, Center for innovation and Bioinformatics Neurological Clinical Research, Massachusetts General Hospital
Oct 911:40
Conference pass
Chair's remarks
Population Genomics
James Duboff, Strategic Partnerships Director, Genomics England
Oct 911:45
Conference pass
Roche’s AI/LLM platform
Large Language Models
Oct 911:45
Conference pass
Predictive & Generative Modelling in Drug Design Opportunities and Challenges of Augmented Intelligence
Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry / Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 911:45
Conference pass
Doing AI properly
AI in Drug Development and Discovery
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Oct 911:45
Conference pass
Using RWD and AI to guide clinical strategy and enhance study design
Real World Evidence
Thirupathi Pattipaka, Director, Advanced Analytics, Novartis
Oct 911:45
Conference pass
Generative AI in Life Sciences – An opportunity like never before
Digital Transformation
Marco Andre, Global Head of Marketing Excellence, Novartis
Oct 911:45
Conference pass
Cryo-em in modern drug discovery
Analytics Platform
Alexey Rak, Head Of Bio Structure And Biophysics, Sanofi
Oct 911:45
Conference pass
Big Data in oncology in Market Access and commercialisation
Big Data in Oncology
Philipp Pauli, Head of Oncology Europe & Canada, a.i., Takeda
Oct 911:45
Conference pass
Turning Applications and Platforms into a Product Architecture
Data Integration + FAIR
Ralph Haffner, VP Research Informatics, Novartis, Biomedical Research
Oct 911:45
Conference pass
In silico trials to speed up clinical development
Bioinformatics + In silico R&D
Oct 911:45
Conference pass
Genetic Diversity at Scale
Population Genomics
Chris Lunt, CTO, NIH
Oct 911:45
Conference pass
Presentation title announced soon
Single Cell Genomics
Oct 912:25
Conference pass
Adapting LLM’s to Pharma Data
Large Language Models
Oct 912:25
Conference pass
Accelerating Design-Make-Test cycles with predictive and generative AI
Cheminformatics
Daniel Kuhn, Director, Head of AI and New Technologies, Medicinal Chemistry & Drug Design, Merck
Oct 912:25
Conference pass
Creating real value through AI in biopharma – beyond the hype!
AI in Drug Development and Discovery
Oct 912:25
Conference pass
5 new ways to sabotage your R&D data platform.
Data Management, Storage and Architecture
Oct 912:25
Conference pass
Embedding real-world evidence into clinical-decision-making across BUPA
Real World Evidence
Lucy Hoppe, Head of Clinical Evidence, Bupa
Oct 912:25
Conference pass
Presentation title announced soon
Digital Transformation
Anthony Rowe, Head of Technology, Global Scientific Information Technology, Johnson & Johnson
Oct 912:25
Conference pass
Bringing Data Science to Regulatory Reporting
Analytics Platform
James Black, Director, Insights Engineering, Roche
Oct 912:25
Conference pass
AI in clinical decision making support
Big Data in Oncology
Christophe Dufour, Global Head Digital Precision Medicine, AstraZeneca
Oct 912:25
Conference pass
FAIR Data Governance
Data Integration + FAIR
Felix Schwagereit, Principal Scientist - Data Harmonization, Roche
Oct 912:25
Conference pass
Unlocking the Future of Cancer Treatment: Pioneering Bioinformatics in Drug Discovery
Bioinformatics + In silico R&D
Ana Maria Florescu, Associate Director, Precision Oncology and Virology, Molecular Partners AG
Oct 912:25
Conference pass
Partnerships for translation; Genomics England’s National Clinical and Research Platform for Precision Medicine
Population Genomics
Kate Witkowska, Strategic Partnerships Director, Genomics England
Oct 912:25
Conference pass
Data analysis frameworks for spatial transcriptomics
Single Cell Genomics
Naveed Ishaque, Group Leader, Berlin Institute of Health at Charité; ELIXIR Germany
Oct 913:05
Conference pass
Scaling the impact of LLM’s to the clinical portfolio
Large Language Models
Jeremy Zhang, Sr Director, Advanced Analytics, Gilead Sciences
Oct 913:05
Conference pass
Presentation title announced soon
Cheminformatics
Werngard Czechtizky, Chair of AZ Global Chemistry Leadership, Astrazeneca
Oct 913:05
Conference pass
Enhancing drug discovery pipeline through rational use of AI approaches
AI in Drug Development and Discovery
Oct 913:05
Conference pass
Efficient Clinical Data Review through AI-driven Clinical Data Transformation: An Abbvie Case Study
Data Management, Storage and Architecture
Aman Thukral, Director -Global Head-Clinical Systems & Digital Operations, Abbvie
Oct 913:05
Conference pass
Real world insights vs real world evidence: Organisation considerations
Real World Evidence
Frank Sifakis, Vice President Real World Evidence,, Gilead
Oct 913:05
Conference pass
Oct 913:05
Conference pass
Machine Learning for DNA Encoded Libraries: Scaling, automation and reproducibility
Analytics Platform
Bartosz Baranowski, Senior Expert Data Science, Novartis
Oct 913:05
Conference pass
Cancer Clinical Data in Genomics England
Big Data in Oncology
Georgia Chan, Senior Data Wrangler/Clinical Data Scientist, Genomics England
Oct 913:05
Conference pass
Metadata governance and FAIR
Data Integration + FAIR
Kenny Baird, Ontologist (Global ODM), Boehringer Ingelheim
Oct 913:05
Conference pass
Increasing productivity in oncology drug discovery through data science and AI
Bioinformatics + In silico R&D
Oct 913:05
Conference pass
Advances in Genomic Medicine
Population Genomics
G Scott Chandler, Global Head, Personalized Healthcare Safety, Roche
Oct 913:05
Conference pass
Explainable patient stratification using single cell omics data
Single Cell Genomics
Jonas Meirer, Data Scientist, CSEM
Oct 914:25
Conference pass
Oct 914:25
Conference pass
Chair's remarks
Cheminformatics
Christian Baber, Chief Portfolio Officer, Pistoia Alliance
Oct 914:25
Conference pass
Chair's remarks
Data Management, Storage and Architecture
Marco Giannitrapani, VP of Global Data & Analytics, Roche
Oct 914:25
Conference pass
Oct 914:25
Conference pass
Chair's remarks
Analytics Platform
Christophe Chabbert, Product Line Manager, Data & Analytics, Roche
Oct 914:25
Conference pass
Chair's remarks
Big Data in Oncology
Philipp Pauli, Head of Oncology Europe & Canada, a.i., Takeda
Oct 914:25
Conference pass
Chair's remarks
Data Integration + FAIR
Ralph Haffner, VP Research Informatics, Novartis, Biomedical Research
Oct 914:25
Conference pass
Chair's remarks
Population Genomics
Kate Witkowska, Strategic Partnerships Director, Genomics England
Oct 914:25
Conference pass
Chair's remarks
Population Genomics
Kate Witkowska, Strategic Partnerships Director, Genomics England
Oct 914:30
Conference pass
Better & Faster: GenAI driven Automation for Research & Development
Large Language Models
Oct 914:30
Conference pass
New modalities in Cheminformatics
Cheminformatics
ioana oprisiu, Data Scientist Cheminformatician, Astrazeneca
Oct 914:30
Conference pass
Use of Functional Genomics in AI Drug Discovery and Development
AI in Drug Development and Discovery
Davide Gianni, Senior Director, Discovery Sciences, AstraZeneca
Oct 914:30
Conference pass
Domain Concept - implementation and challenges
Data Management, Storage and Architecture
Christian Ziemann, Data Domain Architect, Boehringer Ingelheim
Oct 914:30
Conference pass
Real World Evidence to Inform Disease Ideology
Real World Evidence
Catherine Brownstein, Professor, Harvard Medical School
Oct 914:30
Conference pass
Designing clinical trials for success: How empowering mission teams trumps the old world
Digital Transformation
Oct 914:30
Conference pass
Unveiling Data Insights: Roche's Vision for the Ultimate Analytics Platform
Analytics Platform
Benjamin Torben-Nielsen, Product manager, Roche
Oct 914:30
Conference pass
Privacy-preserving distributed analytics
Big Data in Oncology
Jean-Pierre Hubaux, Full Professor, Ecole Polytechnique Fédérale de Lausanne, EPFL
Oct 914:30
Conference pass
FAIR and data catalogue
Data Integration + FAIR
Jörg Werner, Senior Director Data Value Office, BioNTech SE
Oct 914:30
Conference pass
Genomics and disease biology for drug development
Bioinformatics + In silico R&D
Emmanouil Dermitzakis, Vice President and Head of Computational Biology, GSK
Oct 914:30
Conference pass
Genomic applications for modelling diseases in animals- preclinical models
Single Cell Genomics
Danilo Maddalo, Principal Scientist, Genentech
Oct 915:10
Conference pass
PRINCE - AWS based Preclinical Information Center using an LLM chatbot
Large Language Models
Oct 915:10
Conference pass
AI/ML for Drug Discovery: Predicting Animal PK Studies and Molecular Properties
Cheminformatics
Raquel Rodriguez Perez, Principal Scientist Modeling & Simulation, Novartis
Oct 915:10
Conference pass
Novartis drug development
AI in Drug Development and Discovery
Maxwell Lawson, Head of Digital Process Innovation, Novartis
Oct 915:10
Conference pass
Architecting Tomorrow: Unleashing the Power of technology and data architecture in digital transformation
Data Management, Storage and Architecture
Youssef Essa, Head of Pharma Architecture, Bayer
Oct 915:10
Conference pass
MDTs digital imperatives for patient management
Digital Transformation
David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca
Oct 915:10
Conference pass
Patrimony an Internal Platform to Prioritize Targets
Analytics Platform
Francois-Xavier Blaudin, Programme Director, Concepts Data Analytics Road Map, SERVIER
Oct 915:10
Conference pass
Big data to support continuous learning in cancer screening
Big Data in Oncology
Oct 915:10
Conference pass
FAIR applied across the product data life-cycle
Data Integration + FAIR
Oct 915:10
Conference pass
Paris Sacly Cancer Cluster project
Bioinformatics + In silico R&D
Galina Boldina, Senior Data Scientist Bioinformatics, Sanofi
Oct 915:10
Conference pass
Genomeasia 100K
Population Genomics
Oct 915:10
Conference pass
Drug target discovery using single cell genomics
Single Cell Genomics
Altuna Akalin, Group leader, Max Delbrück Center
Oct 915:30
Conference pass
Building Agile Data Foundations for Data Mesh and Generative AI in Biotech
Data Management, Storage and Architecture
Moritz Haag, Senior Consultant, D ONE
Andrei Dmitrenko, Data Analytics Consultant, D ONE
Oct 915:50
Conference pass
LLMs in drug safety and pharmacovigilance
Large Language Models
Sriram Venkateswaran, Senior Safety Data Scientist, Hoffmann La Roche Ltd
Oct 915:50
Conference pass
Topics in molecular machine learning
Cheminformatics
Greg Landrum, Senior Scientist, E.T.H. Zurich
Oct 915:50
Conference pass
Integrating AI in Antibody Drug Discovery
AI in Drug Development and Discovery
Chris Klijn, VP, head of discovery data science & target discovery, Genmab
Oct 915:50
Conference pass
Enabling Scalable AI and Automation with Smart Data Structures
Data Management, Storage and Architecture
Tobias Kropelin, Technology Lead, Novo Nordisk
Oct 915:50
Conference pass
Digital Transformation and Manufacturing
Digital Transformation
Frank Thielmann, Head Function of the Future, Takeda
Oct 915:50
Conference pass
Analytics Platform from an AZ perspective
Analytics Platform
Andrea Possenti, Associate Principal Data Scientist, AstraZeneca
Oct 915:50
Conference pass
Big data/AI transforming precision oncology from pre-clinical to personalised treatment
Big Data in Oncology
Shayoni Dutta, Senior Principal Data Scientist, GlaxoSmithKline
Oct 915:50
Conference pass
Virtual product home
Data Integration + FAIR
Roman Saiz, Product Owner, Roche
Oct 915:50
Conference pass
Accelerating Molecular Glue Discovery through AI/ML & Computation Chemistry
Bioinformatics + In silico R&D
Oct 915:50
Conference pass
Our Future Health; A unique resource for discovery and translational research
Population Genomics
Oct 915:50
Conference pass
Presentation title announced soon
Single Cell Genomics
Yann Abraham, Associate Scientific Director, Janssen Pharmaceutical companies of Johnson & Johnson
Oct 916:40
Conference pass
Chair's remarks
Large Language Models
Ana Kotarcic, Researcher, NLP and Deep Learning, University of Zurich
Oct 916:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Naghmeh Ghazaleh, Neuroscience innovation lead, Roche
Oct 916:40
Conference pass
Chair's remarks
Real World Evidence
Kimberly Wilson, Executive Director Translational Epidemiology, Site Head CITRE, Bristol-Myers Squibb
Oct 916:40
Conference pass
Oct 916:40
Conference pass
Chair's remarks
Big Data in Oncology
Philipp Pauli, Head of Oncology Europe & Canada, a.i., Takeda
Oct 916:40
Conference pass
Chair's remarks
Data Integration + FAIR
Ralph Haffner, VP Research Informatics, Novartis, Biomedical Research
Oct 916:40
Conference pass
Chair's remarks
Population Genomics
James Duboff, Strategic Partnerships Director, Genomics England
Oct 916:45
Conference pass
Application of LLM across R&D chain
Large Language Models
Jiajie Zhang, VP, Global Head of AI and Machine Learning, Data & Data Science, R&D,, Sanofi
Oct 916:45
Conference pass
Automated design in lead discovery and lead optimisation
Cheminformatics
Oct 916:45
Conference pass
Deploying AI for drugging motif-mediated pathogenic protein interactions
AI in Drug Development and Discovery
Manjeet Kumar, Bioinformatics Scientist, EMBL Heidelberg
Oct 916:45
Conference pass
Integrating Data Science Industry Best Practices into Clinical Data Reporting and Analysis Workflows
Data Management, Storage and Architecture
Nicolas Fournier, Senior Biostatistics Expert, AC Immune SA
Oct 916:45
Conference pass
Deep dive into Building a secure data environment to drive RWE generation for 7.5 million citizens
Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS England
Oct 916:45
Conference pass
Empowering medical affairs Generative AI in medical use case
Digital Transformation
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Oct 916:45
Conference pass
Empowerment of data science projects with platform level services.
Analytics Platform
Stefan Schmitz, Lead Product Owner, Bayer AG
Oct 916:45
Conference pass
Core Outcome Sets in Big Data: Current Status and Future Opportunities for Genitourinary Cancers
Big Data in Oncology
Oct 916:45
Conference pass
Ensuring computational and scientific reproducibility in R&D.
Data Integration + FAIR
Oct 916:45
Conference pass
Presentation title announced soon
Bioinformatics + In silico R&D
Francesco Strozzi, Head of Data Science and Bioinformatics, ITeos Therapeutics
Oct 916:45
Conference pass
Panel discussio: How climate change impacts human and planetary health
Population Genomics
Moderator: Stephan Schuster, Professor, Nangyang Technological University
Adrian Egli, Director, Institute of Medical Microbiology, Universitat Zurich
Claudia Mohr, Head of Laboratory of Atmospheric Chemistry, Paul Scherrer Institut
Catherine Larose, Researcher, CNRS
Oct 916:45
Conference pass
Application of Whole Genome Sequencing for Pathogen Surveillance and Outbreak Investigation
Single Cell Genomics
Dunstan Rajendram, Principal Scientist, UK Health Security Agency
Oct 917:05
Conference pass
Developing comprehensive real-world clinical datasets that include radiology images and clinical genomics for lung cancer patients treated with immunotherapy.
Big Data in Oncology
Oct 917:25
Conference pass
Panel discussion: Towards industry standards in LLMs
Large Language Models
Michael Ewing, Product Manager - Regulatory Analytics and Generating Insights, Hoffman-La Roche
Bartosz Baranowski, Senior Expert Data Science, Novartis
Vaibhav Kulkarni, R&D Data Engineering Lead, Debiopharm Int SA
Oct 917:25
Conference pass
Panel discussion: Gene therapies
Cheminformatics
Christina Waters, Chief Executive Officer, RARE Science
Oct 917:25
Conference pass
Panel discussion: Maximising Digital Transformation: Leveraging Technology, Data Architecture, and Navigating Implementation Challenge
Data Management, Storage and Architecture
Gregory Ryslik, CTO, Compass Pathways
Jonathan Wagg, Head of Data Science, AC Immune SA
Oct 917:25
Conference pass
Panel discussion: Talent and career progression across top pharma and technologies
Digital Transformation
Moderator: Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Ashwini Sondur, Head Enterprise Data, Global Informatics, F. Hoffmann-La Roche Ltd
Richardus Vonk, Senior Director and Head of Research and Clinical Sciences Statistics, Bayer
Oct 917:25
Conference pass
Panel discussion: Unleashing the power of Big Data in Oncology
Big Data in Oncology
Moderator: Philipp Pauli, Head of Oncology Europe & Canada, a.i., Takeda
Sid Jain, Head, Global Development Data Science Strategy & Portfolio, Janssen R&D, J&J Innovative Medicine
Iroda Jurabekova, Global Pricing and Market Access Lead, Boehringer Ingelheim
Oct 917:25
Conference pass
Panel discussion: Emerging trends and roles in translational bioinformatics
Bioinformatics + In silico R&D
Moderator: Jake Chen, Professor and Chief Bioinformatics Officer, University of Alabama at Birmingham
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners
Oct 917:25
Conference pass
Panel discussion: How do different population genomics databases support R&D (Drug Discovery & Drug Development)
Population Genomics
Moderator: Quin Wills, CSO, Co Founder, Ochre Bio
James Duboff, Strategic Partnerships Director, Genomics England
Oct 917:25
Conference pass
Panel discussion: Interface of Immune Diversity & Data Sets
Single Cell Genomics
Create your personal agenda –check the favourite icon
Oct 109:00
Conference pass
Deployment of AI in Pharma – a gamechanger for the industry?
Keynotes
Oct 1011:40
Conference pass
Oct 1011:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Oct 1011:40
Conference pass
Oct 1011:40
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Oct 1011:40
Conference pass
Chairs remarks
Image Analysis
Stefan Platz, Senior Vice President Clinical Pharmacology, AstraZeneca
Oct 1011:40
Conference pass
Chair's remarks
Quantum Pharma
Gopal Karemore, Director, Novo Nordisk
Oct 1011:40
Conference pass
Chair's remarks
Precision Medicine Diagnostics and Therapies
Rana Abou Antoun, Global Commercial Director Cell and Gene, Novartis
Oct 1011:40
Conference pass
Chair's remarks
Lab Operations
Oct 1011:45
Conference pass
Patient identification by using LLM
Large Language Models
David Dellamonica, Head, Digital and Innovation, Oncology Europe & Canada, AstraZeneca
Oct 1011:45
Conference pass
Presentation title announced soon
AI in Drug Development and Discovery
Oct 1011:45
Conference pass
RWE within Reverse Translation
Real World Evidence
Jost Leemhuis, Safety Science Partner and Global Business Lead, Roche
Oct 1011:45
Conference pass
Transformation towards lean portfolio management
Digital Transformation
Hannes Richter, Head of Strategy and Portfolio a.i., Novartis
Oct 1011:45
Conference pass
Building a GxP-compliant ML platform for novel data modalities
Analytics Platform
Zeljko Agic, Director, AI Tech Ops, Novo Nordisk
Oct 1011:45
Conference pass
Programmable medicine as a new paradigm in managing and treating chronic diseases
Bioinformatics + In silico R&D
Jake Chen, Professor and Chief Bioinformatics Officer, University of Alabama at Birmingham
Oct 1011:45
Conference pass
Prediction of Molecular Biomarkers: All Roads lead to Rome?
Image Analysis
Adrien Rousset, Global Scientific Director – Computational & Translational Pathology, Amgen
Oct 1011:45
Conference pass
Status quo of algorithms and applications
Quantum Pharma
Michael Streif, Quantum Computing Scientist, Boehringer Ingelheim Pharma GmbH & Co.
Oct 1011:45
Conference pass
European Research Infrastructures advancing Personalised Medicine
Precision Medicine Diagnostics and Therapies
Jens K Habermann, Director General, BBMRI-ERIC
Oct 1011:45
Conference pass
Presentation title announced soon
Lab Operations
Stuart Jackson, Chief Operating Officer, Oncology R&D, AstraZeneca
Oct 1012:05
Conference pass
The Future of Pharma: Leveraging AI for Quick Detection of Protein Crystals
Image Analysis
Oct 1012:25
Conference pass
Evolve or perish - Embracing LLMs and Automation in Clinical Reporting
Large Language Models
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Oct 1012:25
Conference pass
The Application of Knowledge Graphs to Patient Stratification and Biomarker Discovery
AI in Drug Development and Discovery
Miguel Goncalves, Senior Data Scientist, AstraZeneca
Oct 1012:25
Conference pass
Building safe and robust AI applications using data centric ML
Data Management, Storage and Architecture
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 1012:25
Conference pass
Improving diversity in clinical trials
Real World Evidence
Lars Hulstaert, Associate Director Data Science, Johnson & Johnson
Oct 1012:25
Conference pass
Accelerating digital transformation with external partnerships and innovation
Digital Transformation
Lily Wong, VP Head of Partnerships and Strategy, Bayer
Oct 1012:25
Conference pass
Multimodal Cloud Platform
Analytics Platform
Robbie Chabra, Infrastructure Architect, Genomics England
Oct 1012:25
Conference pass
Revolutionising image analysis: Unveiling AstraZeneca's methods
Image Analysis
Stefan Platz, Senior Vice President Clinical Pharmacology, AstraZeneca
Oct 1012:25
Conference pass
Update on selected use cases
Quantum Pharma
Oct 1012:25
Conference pass
Biobanking Enabling Cancer Precision Medicine
Precision Medicine Diagnostics and Therapies
Rosita Kammler, Head Translational Research Coordination, ETOP IBCSG Partners Foundation
Oct 1012:25
Conference pass
Presentation title announced soon
Lab Operations
Amellalih Reza, Global Quality Management and Lab Operations, Bayer
Oct 1013:05
Conference pass
iQNow AI enabled approach to knowledge management
Large Language Models
Aleksandar Kapisoda, Senior Scientist AI & Knowledge Management, Boehringer Ingelheim
Michael Schorpp, Head of Knowledge Management and AI, Boehringer Ingelheim International GmbH
Oct 1013:05
Conference pass
AI in Drug Discovery: Chemistry with Artificial Intelligence
AI in Drug Development and Discovery
Oct 1013:05
Conference pass
KM for IEP
Data Management, Storage and Architecture
Stefano Dal Santo, Head of Knowledge Management, Novartis
Oct 1013:05
Conference pass
The opportunity for digital health tools in prostate cancer
Real World Evidence
Oct 1013:05
Conference pass
Patient journeys/companion apps: what’s next?
Digital Transformation
Oct 1013:05
Conference pass
PhenoMorph: Cell Painting at scale
Analytics Platform
Matthias Orlowski, Principal ML Engineer, Bayer AG
Marc Osterland, Machine Learning Engineer, Bayer
Oct 1013:05
Conference pass
A multimodal, data-centric approach to support biomarker discovery in Oncology
Bioinformatics + In silico R&D
Sakshi Gulati, Director Oncology Data Science Platforms, AstraZeneca
Oct 1013:05
Conference pass
Synthetic Data for Medical Imaging
Image Analysis
Sadegh Mohammadi, Head of Computer Vision & Sound Analysis, Bayer AG
Oct 1013:05
Conference pass
Variability of Quantum machine learning models in the healthcare space
Quantum Pharma
Oct 1013:05
Conference pass
Harnessing the Power of AI-Immunology™: Integrating Predictive Modeling for Therapy Response into Vaccine Strategy Selection
Precision Medicine Diagnostics and Therapies
Jens Kringelum, VP, AI & Innovation, Evaxion Biotech
Oct 1013:05
Conference pass
Ensuring facility design is optimal for R&D success
Lab Operations
Oct 1014:25
Conference pass
Oct 1014:25
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Oct 1014:25
Conference pass
Chair's remarks
Real World Evidence
Catarina Santos, Executive Director of Region Europe, Novartis
Oct 1014:25
Conference pass
Chair's remarks
Digital Transformation
Lily Wong, VP Head of Partnerships and Strategy, Bayer
Oct 1014:25
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Oct 1014:25
Conference pass
Chair's remarks
Image Analysis
Stefan Platz, Senior Vice President Clinical Pharmacology, AstraZeneca
Oct 1014:25
Conference pass
Chair's remarks
Quantum Pharma
Gopal Karemore, Director, Novo Nordisk
Oct 1014:25
Conference pass
Chair's remarks
Precision Medicine Diagnostics and Therapies
Josef El Andari, Vice President of Genomic Medicine, DINAQOR
Oct 1014:25
Conference pass
Oct 1014:30
Conference pass
From Chaos to Clarity: How Advanced Data Engineering and AI are Reshaping Data Ingestion Pipelines in Early Science
Large Language Models
Oct 1014:30
Conference pass
Building the data platform of the future: Enabling AI agents in a responsible way to derive clinical insights
AI in Drug Development and Discovery
Sam Khalil, Vice President, Head of Data Insights, Novo Nordisk
Oct 1014:30
Conference pass
Data storage and data management throughout clinical trials
Data Management, Storage and Architecture
Athene Giesen, Associate Director IT Compliance, Molecular Partners AG
Jürg Lustenberger, Senior Director Quality Assurance, Molecular Partners
Oct 1014:30
Conference pass
The role of AI in advancing pharma manufacturing
Digital Transformation
Oct 1014:30
Conference pass
Scaling Trusted Science to Enterprise through FAIRR Analytics
Analytics Platform
Justin Lecher, Senior Director, Platform & Data Engineering, AstraZeneca
Oct 1014:30
Conference pass
Data Governance in a Clinical Trial Platform implementation– best practices and success factors
Data Integration + FAIR
Oct 1014:30
Conference pass
Coupling protein engineering and AI to develop soluble multi-specific TCR therapies
Bioinformatics + In silico R&D
Oct 1014:30
Conference pass
Stable Diffusion for Pharma Synthetic Image Generation
Image Analysis
Oct 1014:30
Conference pass
Investment framework on Quantum for drug discovery
Quantum Pharma
Johannes Galatsanos, Sloan Fellow & Researcher at Center of Quantum Networks, Massachusetts Institute of Technology
Oct 1014:30
Conference pass
Automation for organoid culture and sorting
Lab Operations
Lucie Jandet, R&D Engineer, CSEM
Oct 1015:10
Conference pass
Application of LLMs in commercial functions
Large Language Models
Oct 1015:10
Conference pass
ML models for drug development in-vivo studies
AI in Drug Development and Discovery
Damian Roqueiro, Senior Scientist, Roche
Oct 1015:10
Conference pass
Introduction of controlled vocabularies in R&D to drive interoperability
Data Management, Storage and Architecture
Mathew Woodwark, Executive Director, AstraZeneca
Oct 1015:10
Conference pass
Redefining medical education: how Mayo Clnic’s XR revolution will save people’s lives
Real World Evidence
Bob Morreale, Senior Division Chair for Immersive and Experiential Learning / Assistant Professor of Biomedical Communications, Mayo Clinic
Oct 1015:10
Conference pass
Presentation title announced soon
Digital Transformation
Cedric Berger, Head of Knowledge Extraction & Integration, Roche
Oct 1015:10
Conference pass
Moving the mountain and finding a more agile way to analyse and report clinical data
Analytics Platform
Oct 1015:10
Conference pass
Accessible lab data (Capturing FAIR data at source)
Data Integration + FAIR
Oct 1015:10
Conference pass
Radiological Imaging Algorithms
Image Analysis
Tao Xu, Senior Data Scientist, Roche
Oct 1015:10
Conference pass
Pushing the boundaries of quantum algorithms of pharma
Quantum Pharma
Agnes Meyder, Senior Scientist, Roche
Oct 1015:10
Conference pass
Novel Technologies for Precision Medicine and Liquid Biopsy Biomarkers
Precision Medicine Diagnostics and Therapies
Mike Makrigiorgos, Professor For Department Of Radiation Oncology, Dana Farber and Harvard Medical School
Oct 1015:10
Conference pass
Oct 1015:30
Conference pass
Unlocking the potential of cell-free RNA for liquid biopsy biomarker and diagnostics
Precision Medicine Diagnostics and Therapies
Bogdan Mateescu, group leader, University of Zurich
Oct 1015:50
Conference pass
Application of LLM in early drug discovery
Large Language Models
Allan Shaw, Corporate Vice President, Novo Nordisk
Oct 1015:50
Conference pass
Industrialized GxP AI/ML at Bayer Cinical Development - deep phenotyping and the promise of AI/ML based covariate adjustment
AI in Drug Development and Discovery
Oct 1015:50
Conference pass
Federated analytics and learning
Real World Evidence
Dominik Heinzmann, Senior Director Data Science, Roche
Oct 1015:50
Conference pass
Bringing remote vision monitoring to patients at scale
Digital Transformation
Leslie Fendt, Global Program Lead (Digital Health), Roche
Oct 1015:50
Conference pass
Leverage Big Data and AI to accelerate patient diagnosis
Analytics Platform
Silvia Cerolini, Head, Digital Transformation and Innovation, Sanofi
Oct 1015:50
Conference pass
Leverage Big Data and AI to accelerate patient diagnosis
Analytics Platform
Silvia Cerolini, Head, Digital Transformation and Innovation, Sanofi
Oct 1015:50
Conference pass
Leverage Big Data and AI to accelerate patient diagnosis
Analytics Platform
Silvia Cerolini, Head, Digital Transformation and Innovation, Sanofi
Oct 1015:50
Conference pass
Challenges of the modern preclinical FAIR Data landscape
Data Integration + FAIR
Andreas Steinbacher, Senior Director Software Products, Novo Nordisk
Oct 1015:50
Conference pass
Vaccine Discovery: AI-immunologyTM Platform for Reduced Risk and Cost in Vaccine Development
Bioinformatics + In silico R&D
Oct 1015:50
Conference pass
Multimodal Programme Genomics England
Image Analysis
Oct 1015:50
Conference pass
Enabling external collaboration to internalise data in a FAIR and data centric principal
Quantum Pharma
Wolfgang Gumpp, Field Application Scientist, Novartis
Oct 1015:50
Conference pass
Donor-derived cell-free DNA in transplantation to improve personalized immunosuppression
Precision Medicine Diagnostics and Therapies
Oct 1016:40
Conference pass
Oct 1016:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Oct 1016:40
Conference pass
Chair's remarks
Real World Evidence
Heide Stirnadel-Farrant, Tumour Lead, Oncology Outcomes Research, AstraZeneca
Oct 1016:40
Conference pass
Chair's remarks
Digital Transformation
Lily Wong, VP Head of Partnerships and Strategy, Bayer
Oct 1016:40
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Oct 1016:40
Conference pass
Chair's remarks
Image Analysis
Stefan Platz, Senior Vice President Clinical Pharmacology, AstraZeneca
Oct 1016:40
Conference pass
Chair's remarks
Quantum Pharma
Gopal Karemore, Director, Novo Nordisk
Oct 1016:40
Conference pass
Chair's remarks
Lab Operations
Oct 1016:45
Conference pass
Developing internal LLM chat agents for literature reviews
Large Language Models
Paul Paul, RWE Lead, UCB
Oct 1016:45
Conference pass
AI/LLMs in digitalising protocols
AI in Drug Development and Discovery
Abhishek Dhanuka, Team lead, Novartis
Oct 1016:45
Conference pass
Enabling open data resources for research
Data Management, Storage and Architecture
Marc Baaden, Research Director, The French National Center for Scientific Research (CNRS)
Oct 1016:45
Conference pass
RWE & technology : a pragmatic stroke development case study
Real World Evidence
Adeline Meilhoc, Head of Global Clinical Development, Acticor Biotech
Oct 1016:45
Conference pass
Automation of Medical Case Review with Help of AI
Digital Transformation
Oct 1016:45
Conference pass
Advanced segmentation with AI/ML
Analytics Platform
David Lopez, Director, Oncology Digital and Technology, gsk
Jorge Manuel Tavares, BI & Analytics Director – Oncology, gsk
Oct 1016:45
Conference pass
User-base Engagement during New Data Capture System Configuration and Deployment.
Data Integration + FAIR
Phin Chooi, Senior Scientist, AstraZeneca
Oct 1016:45
Conference pass
Transforming R&D at Merck through Digital Chemistry and Cross-Domain Synergies
Bioinformatics + In silico R&D
Oct 1016:45
Conference pass
Clinical insights from integrated data sets
Image Analysis
Joerg Degen, Clinical Data Insights Lead, Roche
Oct 1016:45
Conference pass
Quantum Computing for Molecular Biology
Quantum Pharma
Matthias Christandl, Leader of Quantum for Life Center, University of Copenhagen
Oct 1016:45
Conference pass
AI-Based Digital Healthcare Product Development Framework
Precision Medicine Diagnostics and Therapies
Oct 1016:45
Conference pass
Lab automation platform for the development of vaccine formulation
Lab Operations
Oct 1017:05
Conference pass
Radioligand Therapies - A new era in precision medicine
Precision Medicine Diagnostics and Therapies
Jeevan Virk, VP - Radioligand Therapy (RLT) Therapeutic Area Strategy Head, Novartis
Oct 1017:25
Conference pass
Panel discussion: Navigating tomorrow- Implementing LLMs across the value chain
Large Language Models
Abhishek Chatterjee, Director, Solution Design, Novatis
Sridevi Nagarajan, Head, Digital Regulatory Strategy, AstraZeneca UK Ltd
Oct 1017:25
Conference pass
Panel discussion: The Road Map to Transitioning from Ad-hoc AI to Business Value Generating AI
AI in Drug Development and Discovery
Oct 1017:25
Conference pass
Panel discussion: Data-Driven Innovation - Bridging Openness yet Safety in Research and AI Development
Data Management, Storage and Architecture
Moderator: Mateusz Zabolski, Head of Technology - Biosamples, AstraZeneca
Antoine Taly, Researcher, CNRS
Susan Gregurick, Senior Advisory Office of Data Science Strategy, National Institutes of Health
Jesica Hoker, Senior Strategy & Digital Transformation Program Lead, Bayer
Barry Bryne, Global Head of Knowledge Management Strategy, Novartis
Oct 1017:25
Conference pass
Panel discussion: Navigating Real-World Evidence in Pharma: Insights, Applications, and Challenges
Real World Evidence
Moderator: Claudia Vogt, Chief of Staff R&D Data Science & AI, Bayer AG
Heide Stirnadel-Farrant, Tumour Lead, Oncology Outcomes Research, AstraZeneca
Meni Styliadou, VP Distinguished Fellow, Data Science Institute, Takeda Europe R&D
Paul Ashley, Director of Data Science External Innovation, Johnson & Johnson
Moritz Saxenhofer, Senior Manager Translational Research, CSL Behring
Oct 1017:25
Conference pass
Panel discussion: How Digital transformation changed the way we delivered our products to patients
Digital Transformation
Monika Trehan, Digital Collaboration & Licensing Lead, Syngenta AG
Carolina Benjaminsen, Senior Director and Head of Digital Science Academy for R&ED, Novo Nordisk
Ciara Hennessy, Digital Health Strategist, NLC Health Ventures
Leslie Fendt, Global Program Lead (Digital Health), Roche
Oct 1017:25
Conference pass
Panel discussion: Open Source Software: A Game Changer in Clinical Trials?
Analytics Platform
Moderator: Alasdair Thomson, Product Owner, Data Science Automation Group, Novo Nordisk
Oct 1017:25
Conference pass
Panel discussion: 10 years of FAIR: A reflection on what has happened
Data Integration + FAIR
Moderator: Philippe Marc, Executive Director, Global Head Of Integrated Data Sciences, Novartis Biomedical Research
Sabine Österle, Team Lead Data Interoperability, SIB Swiss Institute of Bioinformatics
Athene Giesen, Associate Director IT Compliance, Molecular Partners AG
Karsten Quast, Data Domain Owner Ontologies, Boehringer Ingelheim GmbH
Oct 1017:25
Conference pass
Panel discussion: Is Quantum computing a New paradigm in drug discovery and development?
Quantum Pharma
Moderator: Gopal Karemore, Director, Novo Nordisk
Oct 1017:25
Conference pass
Panel discussion: The ownership of AI for healthcare product development
Precision Medicine Diagnostics and Therapies
Catarina Santos, Executive Director of Region Europe, Novartis
last published: 17/Apr/24 15:45 GMT
Get involved at BioTechX
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events